Recent News

• 08.21.2025 - Quanterix Accelerator Laboratory Awarded Rigorous New York State Clinical Laboratory Permit
• 08.12.2025 - CG 45th Annual Growth Conference
• 08.11.2025 - Quanterix to Present at the Canaccord Genuity 45th Annual Growth Conference
• 08.07.2025 - Quanterix Corporation Q2 2025 Earnings Call
• 08.07.2025 - Quanterix Releases Financial Results for the Second Quarter of 2025
• 08.04.2025 - Quanterix To Report Second Quarter 2025 Financial Results on August 7, 2025
• 08.04.2025 - Quanterix Announces Cooperation Agreement with Kent Lake Capital
• 07.28.2025 - Quanterix Launches Novel p-Tau 205 and p-Tau 212 Assays to Advance Alzheimer's Research at AAIC

Recent Filings

• 08.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.13.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.08.2025 - PRE 14A Other preliminary proxy statements
• 08.07.2025 - 8-K Current report
• 08.07.2025 - EX-99.1 EX-99.1
• 08.07.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.04.2025 - EX-99.1 EX-99.1
• 08.04.2025 - 8-K Current report